SCHEMBL12964185

SCHEMBL12964185

Cc1ccc(-c2nc3cc(N)ccc3nc2C)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.57
ATM Q13315 1/20 0.57
TLR9 Q9NR96 1/20 0.57
KDM4E B2RXH2 9/20 0.49
MAPT P10636 8/20 0.49
ALDH1A1 P00352 6/20 0.49
RAB9A P51151 4/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
NPC1 O15118 3/20 0.49
GAA P10253 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
TP53 P04637 2/20 0.49
HSD17B10 Q99714 2/20 0.49
HPGD P15428 2/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
TDP1 Q9NUW8 1/20 0.47
HSP90AB1 P08238 1/20 0.47
PIK3CG P48736 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22288213 0.93 KMT2A (0.61) KMT2AATMTLR9KDM4EMAPT
SCHEMBL22288240 0.93 KMT2A (0.61) KMT2AATMTLR9KDM4EMAPT
SCHEMBL31087686 0.93 KMT2A (0.61) KMT2AATMTLR9KDM4EMAPT
SCHEMBL12964188 0.87 KMT2A (0.54) KMT2AATMTLR9KDM4EMAPT
SCHEMBL12964189 0.87 KMT2A (0.73) KMT2AATMTLR9KDM4EMAPT
SCHEMBL12964181 0.87 KMT2A (0.54) KMT2AATMTLR9KDM4EMAPT
SCHEMBL1550580 0.87 KMT2A (0.77) KMT2AATMTLR9KDM4EMAPT
SCHEMBL12964204 0.87 KMT2A (0.77) KMT2AATMTLR9KDM4EMAPT
SCHEMBL18082983 0.86 KDM4E (0.65) KDM4EMAPTALDH1A1RAB9AL3MBTL1
SCHEMBL18082972 0.85 KMT2A (0.81) KMT2AATMTLR9KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2691377-B1 AMINOQUINOXALINE DERIVATIVES FOR TREATMENT OF NEURODEGENERATIVE DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENT (C N R S ) (FR) 2018-03-07 EP disclosed
EP-2691377-B1 AMINOQUINOXALINE DERIVATIVES FOR TREATMENT OF NEURODEGENERATIVE DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENT (C N R S ) (FR) 2018-03-07 EP disclosed
US-9434701-B2 Aminoquinoxaline derivatives for treatment of neurodegenerative diseases CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2016-09-06 US disclosed
US-9434701-B2 Aminoquinoxaline derivatives for treatment of neurodegenerative diseases CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2016-09-06 US disclosed
WO-2012131080-A1 AMINOQUINOXALINE DERIVATIVES FOR TREATMENT OF NEURODEGENERATIVE DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2012-10-04 WO disclosed